Drug intelligence / Profile preview

povidone-iodine + lidocaine hydrochloride + triamcinolone acetonide + bupivacaine

Development stage
Unknown
Lead developer
Asclemed USA
Modality
Small Molecules
Administration
Topical, Percutaneous, Intraarticular, Parenteral
01

Overview

This product is a **multi-component small-molecule drug kit** combining **povidone-iodine**, **lidocaine hydrochloride**, **triamcinolone acetonide**, and **bupivacaine** for procedure-related **analgesia, anesthesia, and local or regional anesthesia**. Pharmacologically, lidocaine and bupivacaine are amide local anesthetics that reduce nerve conduction by blocking voltage-gated sodium channels, with lidocaine generally providing faster onset and bupivacaine longer duration; triamcinolone acetonide is a glucocorticoid receptor agonist used to suppress local inflammation; and povidone-iodine is a topical iodophor antiseptic used for skin preparation. Publicly visible examples appear on DailyMed under kit-style brand names such as MLK F4 KIT, BLT-25 KIT, and P-CARE variants, but these products are best understood as compounded or packaged combination kits rather than a single standardized branded asset from one clearly identifiable developer. The combination is described for office or procedural use where antisepsis, local anesthetic effect, and anti-inflammatory support may all be desired, including settings such as injections, nerve blocks, or other local procedures.

Brand names
MLK F4 KITBLT-25 KITBLT25 KITBLT 25 KITP-CARE K40MXP-CARE K80MX
Other names
povidone-iodine + lidocaine hydrochloride + triamcinolone acetonide + bupivacainepovidone-iodine + lidocaine HCl + triamcinolone acetonide + bupivacaine
02

Targets

GR (Glucocorticoid receptor)NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on povidone-iodine + lidocaine hydrochloride + triamcinolone acetonide + bupivacaine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on povidone-iodine + lidocaine hydrochloride + triamcinolone acetonide + bupivacaine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call